• Profile
Close

GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma

Virchows Archiv Nov 15, 2019

Liau JY, Tsai JH, Lan J, et al. - In this study, experts examined the clinicopathological and molecular characteristics of 26 anastomosing hemangiomas (AHs, a separate benign vascular tumor that could be histologically confused with an angiosarcoma). Through Sanger sequencing and MassARRAY analysis, of the 22 reviewed tumors, mutually exclusive mutations in exon 5 of GNA11, GNAQ and GNA14 were recognized in 10, 5, and 5 tumors, respectively, with an overall mutation rate of 91%. Between GNA11-, GNAQ- or GNA14-mutated tumors, no important variations in the clinicopathological peculiarities were noted. Results showed GNA11 mutations and formerly known mutations of its paralogues GNAQ and GNA14, as necessary drivers in the pathogenesis of AH.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay